A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

NCT06767683 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

256

Enrollment

INDUSTRY

Sponsor class

Conditions

Narcolepsy Type 1
Narcolepsy Type 2
Idiopathic Hypersomnia

Interventions

DRUG: ALKS 2680, 4mg
DRUG: ALKS 2680, 6mg
DRUG: ALKS 2680, 8mg
DRUG: ALKS 2680, 10mg
DRUG: ALKS 2680, 14mg
DRUG: ALKS 2680, 18mg

Sponsor

Alkermes, Inc.